Navigation Links
ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
Date:2/2/2010

Software shortens contract closure time for one customer from 2 ½ months to 2 ½ weeks; saves another customer 20% of outsourcing costs

London, United Kingdom (PRWEB) February 2, 2010 -- ClearTrial (www.cleartrial.com), the leading provider of Clinical Trial Operations (CTO) software, today announced that it will be demonstrating the software's capabilities to drive greater outsourcing efficiency to an audience of more than 125 clinical outsourcing professionals at the 3rd Annual Clinical Outsourcing World conference in London. The event attracts biopharmaceutical companies from around the globe to hear top clinical outsourcing experts discuss major strategic and operational challenges of partnering with clinical research organizations (CROs).

Attendees of the conference will discover firsthand how ClearTrial software is helping biopharmaceutical companies worldwide gain speed and consistency and cut costs in the outsourcing function:

 
  • Rapid "what-if" scenarios to choose the best outsourcing model for studies
  • Accurate cost comparisons between types of CROs
  • Fast, consistent RFP development
  • Streamlined contract negotiations
  • Greater visibility to cost and resource requirements, both internal and outsourced
  • Minimized change orders and their corresponding impact on the organization

ClearTrial software is built on an activity-based or “project management” architecture, which enables
'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related biology technology :

1. ClearTrial Names Proven Enterprise Software and Life Sciences Sales Leader Craig Smith as Vice President of Sales
2. ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development
3. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
4. ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
5. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
6. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
7. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
8. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
9. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
10. S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders
11. Scientists demonstrate multibeam, multi-functional lasers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
(Date:5/22/2013)... A recent study from researchers in ... find that those who took probiotics were able to run ... study showed that in extreme heat conditions, probiotics were able ... acne treatment explains what this new discovery means ... their skin condition. , While researchers tote the benefits ...
(Date:5/21/2013)... 2013 First patients dosed with ... bromide designed using Prosonix, particle engineering platform ... of inhaled Respiratory Medicines by Design , has ... will assess its effect on lung function and the ... moderate to severe chronic obstructive pulmonary disease (COPD). The ...
(Date:5/21/2013)... Custom Learning Designs, Inc.(CLD) unveils the ... Tin Can API combined with its own proprietary ... leading developer of training content and solutions for ... , Tin Can API is a cost-effective learning ... more accurately measure the Return on Education (ROE) ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Alpha ... distributor , will be exhibiting for the 13th ... of Medical Instrumentation (AAMI) 2013 Conference and Expo. ... support, distribute, and manufacture healthcare technologies. This year’s ... Long Beach, California. , The three-day event ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2
... 2011 UV Flu Technologies, Inc. ( ... to announce it has expanded its International Distribution by adding ... its relationship with the Company,s Distributor in India, Ormed Systems, ... as well as other parts of the world. The Company ...
... Avaxia Biologics, Inc. , a privately-held biotech ... the gastrointestinal tract, announced today that the company completed ... A angel-led financing. Cherrystone Angels of Providence, Rhode Island ... and other undisclosed individuals. Mr. Robert Manning, the co-Chairman ...
... SQNM ), a life sciences company providing innovative ... Lazard Capital Markets 8th Annual Healthcare Conference at the Pierre ... Harry F. Hixson, Jr, Ph.D., Chairman and CEO, and Ronald ... will present on Tuesday, November 15, 2011 beginning at 8:30 ...
Cached Biology Technology:UV Flu Technologies Expands Its International Footprint 2UV Flu Technologies Expands Its International Footprint 3Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease 2Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference 2
(Date:5/22/2013)... Researchers working to improve durability in fuel cell ... University, have discovered links between electrode degradation processes ... quantifying the effects of electrode degradation stressors in ... membrane lifetime. , The findings of the study, ... the latest in a long-term study at Burnaby-based ...
(Date:5/22/2013)... drastically reduces the time and effort needed to ... biotechnology, scientists are reporting. Published in the journal ... the way for more rapid development of designer ... activities. , Keith Shearwin and colleagues explain that ... material DNA into a bacterium,s genome is critical ...
(Date:5/22/2013)... on how climate change will affect interactions between species ... Journal of Animal Ecology . This knowledge, they say, ... of how species are likely to be impacted by ... recognition among biologists that climate change is affecting how ... going to have very important consequences for the stability ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5
... Carolina State University have found a specific gene in corn that ... diseases. In a paper ... Sciences , NC State plant pathologists and crop scientists pinpoint ... to Southern leaf blight, gray leaf spot and Northern leaf blight, ...
... use of biotechnology increases and more companies move ... to begin full-scale commercialization of seed mixtures in ... will become even more difficult. "Seed mixtures ... of larval behavior and greater adoption of insecticidal ...
... has for the first time found that female-to-male transsexual ... traits. , The Medical Research Council (MRC) funded ... and Developmental Disorders , has important implications for the ... persists into adulthood, and for the ,extreme male brain, ...
Cached Biology News:Study shows corn gene provides resistance to multiple diseases 2Seed mixtures and insurance pest management: Future norm in the Corn Belt? 2Female-to-male transsexual people have more autistic traits 2
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
Trop-2 Purified Anti-Human clone 162-46, Isotype Mouse IgG 1 , 100 µg Consult technical datasheet for details....
... BAC (100+kb), fosmid (40kb), and large plasmid ... any othe BAC vector. On command 20-50 ... easy recombinant DNA purification. Available with blue-white ... vectors for the highest insert stability. Kits ...
... Adapted to Sf-900 II ... isolated from Spodoptera frugiperda ... cells (1). The Sf21 ... serum-free suspension culture in ...
Biology Products: